Company works to adapt human therapies for animals

02/5/2013 | Boston Herald

Aratana, a company that licenses and tailors compounds from human drugs for animal health conditions, expects to bring its therapies to the U.S. and European markets in 2016. The company is developing a pain medication for pets with osteoarthritis, an appetite stimulant and a pet formulation of Novocain, according to physician and CEO Steven St. Peter.

View Full Article in:

Boston Herald

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN